Farms.com Home   News

USDA's $35M push to increase domestic fertilizer supply

Aug 30, 2024
By Farms.com

$35 Million grant to strengthen US fertilizer production

 

In a strategic move announced by USDA Secretary Tom Vilsack at the Farm Progress Show in Boone, Iowa, the USDA is dedicating $35 million to amplify domestic fertilizer production. This initiative, part of the Fertilizer Production Expansion Program (FPEP), supports independent business owners in seven states to advance technology and expand operations.

The program aims to create 768 new jobs and increase fertilizer production capacity by over 5.6 million tons. This significant push will help stabilize fertilizer prices, which have doubled due to factors like the ongoing war in Ukraine and competitive limitations in the industry.

Companies such as Dramm Corp. in Wisconsin are set to expand their sustainable practices, utilizing fish waste to produce eco-friendly fertilizers. Meanwhile, AdvanSix in Virginia will escalate its output to meet growing demands along the East Coast.

This investment by the administration underlines a commitment to not only enhance agricultural productivity but also to implement climate-smart solutions and strengthen rural economies.

It’s a comprehensive approach to foster innovation and competitiveness in agriculture while addressing the pressing challenges of food security and environmental sustainability.

By bolstering the production capabilities within the U.S., the USDA is not only aiding in reducing dependency on imports but also fortifying the agricultural sector against future disruptions.

This initiative is part of a broader effort to transform America's food system, ensuring a resilient, equitable, and sustainable food landscape for future generations.


Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.